FDA Inspection 1089685 — Insys Therapeutics Inc
The FDA completed an inspection of Insys Therapeutics Inc on April 18, 2019 in Chandler, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chandler, AZ (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)